Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-05 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion +5,000 $4.70 $24K 35,000
2017-06-05 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sale −5,000 $20.00 $100K 30,000
2017-06-05 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion · Employee stock option (right to buy) −5,000 $4.70 $24K 65,448
2017-05-18 Jackson Scott Thomas Director Grant or award · Stock Option (right to buy) +10,000 10,000

Page 35 of 35 · 684 trades